Company intelligence / Profile preview

Vitrolife

Gothenburg/Göteborgs Stad, Västra Götaland County, Swedenvitrolife.com ↗

Ownership: Public · VITR
Development stage: Other

Overview

Vitrolife’s products are widely used in fertility clinics worldwide to improve outcomes at every stage of the IVF process. The company’s solutions are considered industry standard, with a strong reputation for quality control and clinical efficacy. No specific clinical trial results are published as the company provides devices, media, and services rather than therapeutics.

Therapeutic areas: Women's Health
Modalities: Device (medical devices for IVF)Biologic (culture media and related products)Genetic testing services (for embryo selection and reproductive health)
Industry: Molecular Diagnostics

Partnerships

Strategic partnerships with fertility clinics and research institutes globally; specific names not listed.

Financials

Market cap: $1.6B
Total revenue: $348.4M
Enterprise value: $1.7B

Beyond the preview

Go deeper on Vitrolife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitrolife.